Liver Transplantation at Mayo Clinic Florida

David D. Lee, Kristopher P. Croome, Dana K. Perry, Justin M. Burns, Justin H Nguyen, Andrew P. Keaveny, C. Burcin Taner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Over the sixteen year history of liver transplantation (LT) at Mayo Clinic in Jacksonville, Florida (MCF), we have maintained a practice devoted to excellence in pre- and post-LT management for patients suffering from end stage liver disease. With an emphasis on quality, MCF has made several adjustments with the goal of better utilizing marginal grafts for both successful post-transplant outcomes and minimizing waitlist mortality. This systematic approach is most exemplified in our experience with donation after cardiac death (DCD) liver allografts. Understanding the events during procurement has been critical to reducing the complications associated with donor warm ischemia time that are unique to DCD allografts. Better matching of donors to recipients has helped identify patients who are safe to receive more marginal grafts with successful patient and graft survival. Recognizing the spectrum of degree of sickness in patients undergoing LT, we implemented a multidisciplinary approach that allows for the avoidance of the intensive care unit after LT. In these ways, MCF continues to distinguish itself as an innovator in the field of transplantation for the benefit of continued better care for our patients suffering from end stage liver disease.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalClinical transplants
StatePublished - 2014

Fingerprint

Liver Transplantation
End Stage Liver Disease
Transplants
Allografts
Tissue Donors
Warm Ischemia
Graft Survival
Intensive Care Units
Patient Care
Transplantation
Mortality
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, D. D., Croome, K. P., Perry, D. K., Burns, J. M., Nguyen, J. H., Keaveny, A. P., & Taner, C. B. (2014). Liver Transplantation at Mayo Clinic Florida. Clinical transplants, 83-90.

Liver Transplantation at Mayo Clinic Florida. / Lee, David D.; Croome, Kristopher P.; Perry, Dana K.; Burns, Justin M.; Nguyen, Justin H; Keaveny, Andrew P.; Taner, C. Burcin.

In: Clinical transplants, 2014, p. 83-90.

Research output: Contribution to journalArticle

Lee, DD, Croome, KP, Perry, DK, Burns, JM, Nguyen, JH, Keaveny, AP & Taner, CB 2014, 'Liver Transplantation at Mayo Clinic Florida', Clinical transplants, pp. 83-90.
Lee DD, Croome KP, Perry DK, Burns JM, Nguyen JH, Keaveny AP et al. Liver Transplantation at Mayo Clinic Florida. Clinical transplants. 2014;83-90.
Lee, David D. ; Croome, Kristopher P. ; Perry, Dana K. ; Burns, Justin M. ; Nguyen, Justin H ; Keaveny, Andrew P. ; Taner, C. Burcin. / Liver Transplantation at Mayo Clinic Florida. In: Clinical transplants. 2014 ; pp. 83-90.
@article{576872f65b664f2a877da403d00441e3,
title = "Liver Transplantation at Mayo Clinic Florida",
abstract = "Over the sixteen year history of liver transplantation (LT) at Mayo Clinic in Jacksonville, Florida (MCF), we have maintained a practice devoted to excellence in pre- and post-LT management for patients suffering from end stage liver disease. With an emphasis on quality, MCF has made several adjustments with the goal of better utilizing marginal grafts for both successful post-transplant outcomes and minimizing waitlist mortality. This systematic approach is most exemplified in our experience with donation after cardiac death (DCD) liver allografts. Understanding the events during procurement has been critical to reducing the complications associated with donor warm ischemia time that are unique to DCD allografts. Better matching of donors to recipients has helped identify patients who are safe to receive more marginal grafts with successful patient and graft survival. Recognizing the spectrum of degree of sickness in patients undergoing LT, we implemented a multidisciplinary approach that allows for the avoidance of the intensive care unit after LT. In these ways, MCF continues to distinguish itself as an innovator in the field of transplantation for the benefit of continued better care for our patients suffering from end stage liver disease.",
author = "Lee, {David D.} and Croome, {Kristopher P.} and Perry, {Dana K.} and Burns, {Justin M.} and Nguyen, {Justin H} and Keaveny, {Andrew P.} and Taner, {C. Burcin}",
year = "2014",
language = "English (US)",
pages = "83--90",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Liver Transplantation at Mayo Clinic Florida

AU - Lee, David D.

AU - Croome, Kristopher P.

AU - Perry, Dana K.

AU - Burns, Justin M.

AU - Nguyen, Justin H

AU - Keaveny, Andrew P.

AU - Taner, C. Burcin

PY - 2014

Y1 - 2014

N2 - Over the sixteen year history of liver transplantation (LT) at Mayo Clinic in Jacksonville, Florida (MCF), we have maintained a practice devoted to excellence in pre- and post-LT management for patients suffering from end stage liver disease. With an emphasis on quality, MCF has made several adjustments with the goal of better utilizing marginal grafts for both successful post-transplant outcomes and minimizing waitlist mortality. This systematic approach is most exemplified in our experience with donation after cardiac death (DCD) liver allografts. Understanding the events during procurement has been critical to reducing the complications associated with donor warm ischemia time that are unique to DCD allografts. Better matching of donors to recipients has helped identify patients who are safe to receive more marginal grafts with successful patient and graft survival. Recognizing the spectrum of degree of sickness in patients undergoing LT, we implemented a multidisciplinary approach that allows for the avoidance of the intensive care unit after LT. In these ways, MCF continues to distinguish itself as an innovator in the field of transplantation for the benefit of continued better care for our patients suffering from end stage liver disease.

AB - Over the sixteen year history of liver transplantation (LT) at Mayo Clinic in Jacksonville, Florida (MCF), we have maintained a practice devoted to excellence in pre- and post-LT management for patients suffering from end stage liver disease. With an emphasis on quality, MCF has made several adjustments with the goal of better utilizing marginal grafts for both successful post-transplant outcomes and minimizing waitlist mortality. This systematic approach is most exemplified in our experience with donation after cardiac death (DCD) liver allografts. Understanding the events during procurement has been critical to reducing the complications associated with donor warm ischemia time that are unique to DCD allografts. Better matching of donors to recipients has helped identify patients who are safe to receive more marginal grafts with successful patient and graft survival. Recognizing the spectrum of degree of sickness in patients undergoing LT, we implemented a multidisciplinary approach that allows for the avoidance of the intensive care unit after LT. In these ways, MCF continues to distinguish itself as an innovator in the field of transplantation for the benefit of continued better care for our patients suffering from end stage liver disease.

UR - http://www.scopus.com/inward/record.url?scp=84940987574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940987574&partnerID=8YFLogxK

M3 - Article

C2 - 26281131

AN - SCOPUS:84940987574

SP - 83

EP - 90

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -